- Research Article
- 10.1016/j.jtct.2025.12.381
Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus As Gvhd Prophylaxis - a Mayo Clinic Experience
- Feb 01, 2026
- Transplantation and Cellular Therapy
- Hassan B Alkhateeb + 14 more +14
Publications from 2021 to 2026
Showing 5 of 5 papers
Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus As Gvhd Prophylaxis - a Mayo Clinic Experience
Coronary Artery Calcification as a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide for GVHD Prophylaxis.
Factors Predicting Survival in Patients with TP53-Mutated Myeloid Neoplasms Following Allogeneic Stem Cell Transplant
Five Day Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) in Stage 0-II Breast Cancer: A Report of 218 Cases With Up to 39 Month Follow-Up
PP36 Presentation Time: 11:50 AM: Five Day Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) in Stage 0-II Breast Cancer: A Report of 208 Cases with up to 39 Month Follow-Up